Literature DB >> 19331456

Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats.

Michelle R Ciucci1, Allison M Ahrens, Sean T Ma, Jacqueline R Kane, E Blake Windham, Martin T Woodlee, Timothy Schallert.   

Abstract

Vocal deficits are prevalent and debilitating in Parkinson's disease. These deficits may be related to the initial pathology of the nigrostriatal dopamine neurons and resulting dopamine depletion, which contributes to dysfunction of fine motor control in multiple functions. Although vocalization in animals and humans may differ in many respects, we evaluated complex (50-kHz) ultrasonic mate calls in 2 rat models of Parkinson's disease, including unilateral infusions of 6-hydroxydopamine to the medial forebrain bundle and peripheral administration of a nonakinesia dose of the dopamine antagonist haloperidol. We examined the effects of these treatments on multiple aspects of the acoustic signal. The number of trill-like (frequency modulated) 50-kHz calls was significantly reduced, and appeared to be replaced by simpler (flat) calls. The bandwidth and maximum intensity of simple and frequency-modulated calls were significantly decreased, but call duration was not. Our findings suggest that the nigrostriatal dopamine pathway is involved to some extent in fine sensorimotor function that includes USV production and complexity. (c) 2009 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331456      PMCID: PMC2737695          DOI: 10.1037/a0014593

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  46 in total

1.  Precontact 50-kHz vocalizations in male rats during acquisition of sexual experience.

Authors:  M Bialy; M Rydz; L Kaczmarek
Journal:  Behav Neurosci       Date:  2000-10       Impact factor: 1.912

2.  Neurobiology of 50-kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies.

Authors:  Jeffrey Burgdorf; Paul L Wood; Roger A Kroes; Joseph R Moskal; Jaak Panksepp
Journal:  Behav Brain Res       Date:  2007-03-19       Impact factor: 3.332

3.  Levodopa-induced alterations in speech rate in advanced Parkinson's disease.

Authors:  Miet De Letter; Patrick Santens; Marc De Bodt; Paul Boon; John Van Borsel
Journal:  Acta Neurol Belg       Date:  2006-03       Impact factor: 2.396

4.  Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey.

Authors:  L Hartelius; P Svensson
Journal:  Folia Phoniatr Logop       Date:  1994       Impact factor: 0.849

5.  Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.

Authors:  L O Ramig; S Sapir; S Countryman; A A Pawlas; C O'Brien; M Hoehn; L L Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

6.  Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease.

Authors:  S Gallena; P J Smith; T Zeffiro; C L Ludlow
Journal:  J Speech Lang Hear Res       Date:  2001-12       Impact factor: 2.297

7.  Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease.

Authors:  F Klostermann; F Ehlen; J Vesper; K Nubel; M Gross; F Marzinzik; G Curio; T Sappok
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-31       Impact factor: 10.154

8.  Sex differences in the incidence and sonographic characteristics of antipredator ultrasonic cries in the laboratory rat (Rattus norvegicus).

Authors:  R J Blanchard; R Agullana; L McGee; S Weiss; D C Blanchard
Journal:  J Comp Psychol       Date:  1992-09       Impact factor: 2.231

9.  Analysis of 22 kHz ultrasonic vocalization in laboratory rats: long and short calls.

Authors:  S M Brudzynski; F Bihari; D Ociepa; X W Fu
Journal:  Physiol Behav       Date:  1993-08

10.  Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients.

Authors:  J A Logemann; H B Fisher; B Boshes; E R Blonsky
Journal:  J Speech Hear Disord       Date:  1978-02
View more
  71 in total

1.  A translational approach to vocalization deficits and neural recovery after behavioral treatment in Parkinson disease.

Authors:  Michelle R Ciucci; Lisa Vinney; Emerald J Wahoske; Nadine P Connor
Journal:  J Commun Disord       Date:  2010-04-08       Impact factor: 2.288

Review 2.  Targeted exercise therapy for voice and swallow in persons with Parkinson's disease.

Authors:  John A Russell; Michelle R Ciucci; Nadine P Connor; Timothy Schallert
Journal:  Brain Res       Date:  2010-03-15       Impact factor: 3.252

3.  Subglottal pressure, tracheal airflow, and intrinsic laryngeal muscle activity during rat ultrasound vocalization.

Authors:  Tobias Riede
Journal:  J Neurophysiol       Date:  2011-08-10       Impact factor: 2.714

4.  Cross-activation and detraining effects of tongue exercise in aged rats.

Authors:  Allison J Schaser; Michelle R Ciucci; Nadine P Connor
Journal:  Behav Brain Res       Date:  2015-10-23       Impact factor: 3.332

5.  Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.

Authors:  Cynthia A Kelm-Nelson; Katie M Yang; Michelle R Ciucci
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

6.  Decreased approach behavior and nucleus accumbens immediate early gene expression in response to Parkinsonian ultrasonic vocalizations in rats.

Authors:  Joshua D Pultorak; Cynthia A Kelm-Nelson; Lauren R Holt; Katherine V Blue; Michelle R Ciucci; Aaron M Johnson
Journal:  Soc Neurosci       Date:  2015-09-14       Impact factor: 2.083

7.  Cocaine deprivation effect: cue abstinence over weekends boosts anticipatory 50-kHz ultrasonic vocalizations in rats.

Authors:  Esther Y Maier; Allison M Ahrens; Sean T Ma; Timothy Schallert; Christine L Duvauchelle
Journal:  Behav Brain Res       Date:  2010-05-12       Impact factor: 3.332

8.  Changes to Ventilation, Vocalization, and Thermal Nociception in the Pink1-/- Rat Model of Parkinson's Disease.

Authors:  Rebecca A Johnson; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

9.  Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.

Authors:  Laura M Grant; Franziska Richter; Julie E Miller; Stephanie A White; Cynthia M Fox; Chunni Zhu; Marie-Francoise Chesselet; Michelle R Ciucci
Journal:  Behav Neurosci       Date:  2014-04       Impact factor: 1.912

10.  Deep brain stimulation exacerbates hypokinetic dysarthria in a rat model of Parkinson's disease.

Authors:  Nathaniel O King; Collin J Anderson; Alan D Dorval
Journal:  J Neurosci Res       Date:  2015-10-26       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.